News Call for inquiry into NHS contaminated blood scandal Former health secretary says scandal was "criminal" cover-up.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
News NHS funding crisis affecting community services - report Financial pressures on the health service are affecting community services, such as testing for sexually transmitted diseases and district nursing, according to a new report by The King’s F
Gilead Gilead aims to challenge GSK's HIV drug Tivicay But GSK hit back with plans for two-drug regimen.
News Can Gilead find another Pharmasset in 2017? Company needs to make acquisition to grow, admits CEO.
News FDA probing cancer cases with Bluebird's CALD gene therapy The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
